Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation

Therapeutics and Clinical Risk Management

Volumn 3, Issue 2, 2007, Pages 277-289

  Kendirci, Muammer ^a   Salem, Emad ^b   Hellstrom, Wayne J G ^b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Dapoxetine; Fluoxetine; Paroxetine; Premature ejaculation; Selective serotonin reuptake inhibitor; Sertraline; Sildenafil; Topical cream

Indexed keywords

ALCOHOL; ANESTHETIC AGENT; CLOMIPRAMINE; DAPOXETINE; DRUG METABOLITE; FLUOXETINE; HERBACEOUS AGENT; IMIPRAMINE; INDATRALINE; LIDOCAINE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PRAZOSIN; PRILOCAINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; VARDENAFIL;

ANOREXIA; BEHAVIOR THERAPY; BURNING SENSATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EJACULATION DISORDER; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; FLUSHING; HUMAN; INSOMNIA; LIBIDO DISORDER; MALE SEXUAL DYSFUNCTION; META ANALYSIS; MONOTHERAPY; NAUSEA; NERVOUSNESS; NEUROBIOLOGY; NONHUMAN; OFF LABEL DRUG USE; PAIN; PATHOPHYSIOLOGY; PREMATURE EJACULATION; PSYCHOTHERAPY; REVIEW; RHINITIS; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING; XEROSTOMIA;

EID: 34249987338     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: 10.2147/tcrm.2007.3.2.277     Document Type: Review

References (98)

1. [APA] American Psychiatric Association. 2000. The Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association.
2. Abdel-hamid IA, El Naggar EA, El Gilany AH. 2001. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res, 13:41-5.
3. Ahienius S, Larsson K, Svensson L, et al. 1981. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav, 15:785-92.
4. Andersson KE. 2001. Neurotransmission and drug effects in urethral smooth muscle. Scand J Urol Nephrol Suppl, 26-34; discussion 106-25.
5. Andersson KR, Mulhall JP, Wyllie MG. 2006. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int, 97:311-5.
6. Berendsen HH, Broekkamp CL. 1994. Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure. Eur J Pharmacol, 253:83-9.
7. Berkovitch M, Keresteci AG, Koren G. 1995. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol, 154:1360-1.
8. Bialy M, Beck J, Abramczyk P, et al. 1996. Sexual behavior in male rats after nitric oxide synthesis inhibition. Physiol Behav, 60:139-43.
9. Boolell M, Allen MJ, Ballard SA, et al. 1996. Sildenafil:an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res, 8:47-52.
10. Bradley WE, Farrell DF, Ojemann GA. 1998, Human cerebrocortical potentials evoked by stimulation of the dorsal nerve of the penis. Somatosens Mot Res, 15:118-27.
11. Carson C, Glasser DB, Laumann EO, et al. 2003. Prevalence and correlates of premature ejaculation among men aged 40 years and older: a United States nationwide population-based study [abstract]. J Urol, Abstract 1249.
12. Chen J, Greenstein A, Mabjeesh NJ, et al. 2001. Role of sildenafil treatment in premature ejaculation. Int J Impot Res, 13:548.
13. Chen J, Mabjeesh NJ, Matzkin H, et al. 2003 Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology, 61:197-200.
14. Choi HK, Jung GW, Moon KR, et al. 2000. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology, 55:257-61.
15. Coffey DS. 1988. Androgen action and the sex accessory tissues. New York: Raven Press.
16. Dixon JS, Jen PY. 1995. Development of nerves containing nitric oxide synthase in the human male urogenital organs. Br J Urol, 76:719-25.
17. Djoseland O, Gordeladze JO, Hoglo S, et al. 1980. Evidence for androgen-dependent phosphodiesterase activity in rat seminal vesicle and epididymis. Int J Androl, 3:363-6.
18. Dresser M, Lindert K, Lin D, et al. 2004. Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers [online]. Accessed Jan 21 2005. URL: http://ascpt.org/pres/2004/2004Abstracts.pdf.
19. Dresser MJ, Desai D, Gidwani S, et al. 2006. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res, 18:104-10.
20. Eli Lilly and Company. 2005. Prozac (fluoxetine hydrochloride) prescribing information. Indianapolis, Ind [online]. Accessed 11 April 2007. URL: http://pi.lilly.com/us/prozac.pdf.
21. Foreman MM, Hall JL, Love RL. 1989. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci, 45:1263-70.
22. Frith D, Gibson A. 2000. Sildenafil citrate on nitrergic transmission in anococcygeus muscles from the urogenital system of male and female mice. Eur J Pharmacol, 400:305-12.
23. Gengo PJ, Giuliano F, McKenna KE, et al. 2005. Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation [abstract]. J Urol, 173:239, Abstract 878.
24. GlaxoSmithKline. 2005. Paxil (paroxetine hydrochloride) Tablets and oral suspension prescribing information [online]. Accessed 11 April 2007. URL: http://us.gsk.com/products/assetts/us_paxil.pdf.
25. Godpodinoff ML. 1989. Premature ejaculation:clinical subgroups and etiology. J Sex Marital Ther, 15:130-4.
26. Goldstein I. 2003. Premature to early ejaculation: a sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine. Int J Impot Res, 15:307-8.
27. Haensel SM, Rowland DL, Kallan KT. 1996. Clomipramine and sexual function in men with premature ejaculation and controls. J Urol, 156:1310-5.
28. Hedlund P, Ekstrom F, Larsson B, et al. 1997. Heme oxygenase and NO-synthase in the human prostate--relation to adrenergic, cholinergic and peptide-containing nerves. J Auton Nerv Syst, 63:115-26.
29. Hellstrom WJ. 2004. Dapoxetine HCl for the treatment of premature ejaculation:a phase II, randomized, double-blind, placebo-controlled study. J Sex Med.
30. Hellstrom WJ, Althof S, Gittelman M, et al. 2005. Dapoxetine for the treatment of men with premature ejaculation:Dose-finding analysis. AUA Annual Meeting. San Antonio, TX.
31. Hiemke C, Hartter S. 2000. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther, 85:11-28.
32. Hsieh JT, Chang HC, Law HS, et al. 1998. In vivo evaluation of serotonergic agents and alpha-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation. Br J Urol, 82:237-40.
33. Hull EM, Lumley LA, Matuszewich L, et al. 1994. The roles of nitric oxide in sexual function of male rats. Neuropharmacology, 33:1499-504.
34. Jain NK, Patil CS, Singh A, et al. 2001. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res, 909:170-8.
35. Jannini EA, Simonelli C, Lenzi A. 2002. Disorders of ejaculation. J Endocrinol Invest, 25:1006-19.
36. Jen PY, Dixon JS. 1995. Development of peptide-containing nerves in the human fetal prostate gland. J Anat, 187:169-79.
37. Jen PY, Dixon JS, Gosling JA. 1997. Co-localization of nitric oxide synthase, neuropeptides and tyrosine hydroxylase in nerves supplying the human post-natal vas deferens and seminal vesicle. Br J Urol, 80:291-9.
38. Kameya Y, Deguchi A, Yokota Y. 1997. Analysis of measured values of ejaculation time in healthy males. J Sex Marital Ther, 23:25-8.
39. Kaplan HS, Kohl RN, Pomeroy WB, et al. 1974. Group treatment of premature ejaculation. Arch Sex Behav, 3:443-52.
40. Kara H, Aydin S, Yucel M, et al. 1996. The efficacy of fluoxetine in the treatment of premature ejaculation:a double-blind placebo controlled study. J Urol, 156:1631-2.
41. + influx in guinea-pig vas deferens. Exp Physiol, 85:387-98.
42. Kim SC, Seo KK. 1998. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation:a double-blind, placebo controlled study. J Urol, 159:425-7.
43. Kim SC, Seo KK, Han JH, et al. 2000. Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study. J Urol, 163:1988-91.
44. Kim SW, Lee SH, Paick JS. 2004. In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously. Int J Impot Res, 16:427-32.
45. Laumann EO, Nicolosi A, Glasser DB, et al. 2005. Sexual problems among women and men aged 40-80 y:prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res, 17:39-57.
46. Laumann EO, Paik A, Rosen RC. 1999. Sexual dysfunction in the United States:prevalence and predictors. JAMA, 281:537-44.
47. Lazona AF, Castane ER. 2003. Premature ejaculation:sildenafil plus sertraline versus sertraline alone and sildenafil alone [Abstract 956]. J Urol, 169:247.
48. Lobik L, Cytron S, Kravchick S, et al. 2003. The effect of sildenafil citrate in the treatment of secondary rapid ejaculation. J Urol, 13:378.
49. Machtens S, Ckert S, Stief CG, et al. (2003) Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro. Urology, 61:479-83.
50. McMahon CG. 1998. Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Res, 10:181-4; discussion 185.
51. McMahon CG, Abdo C, Incrocci L, et al. 2004. Disorders of orgasm and ejaculation. J Sex Med, 1:58-65.
52. McMahon CG, Touma K. 1999. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol, 161:1826-30.
53. Mallinckrodt Pharmaceuticals. 2007. Anafranil (Clomipramine Hydrochloride Capsules USP 25 mg, 50 mg, and 75 mg) Rx only. Prescribing information [online]. Accessed4 April 2007. URL: http://pharmaceuticals.mallinckrodt.com/_attachments/PackageInserts/ 01%20Anafrenil%20REV%20020305.pdf. Masters WH, Johnson vE. 1970. Human Sexual Inadequacy. Boston: Little, Brown and Co.
54. Mattos RM, Lucon AM. 2005. Tadalafil and slow-release fluoxetine in premature ejaculation:a prospective study. AUA Annual Meeting. San Antonio, TX.
55. Medina P, Segarra G, Torondel B, et al. 2000. Inhibition of neuroeffector transmission in human vas deferens by sildenafil. Br J Pharmacol, 131:871-4.
56. Modi NB, Dresser M, Desai D, et al. 2005. Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol [abstract]. J Urol, 173:239, Abstract 879.
57. Modi NB, Dresser MJ, Simon M, et al. 2006. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol, 46:301-9.
58. Montague DK, Jarow J, Broderick GA, et al. 2004. AUA guideline on the pharmacologic management of premature ejaculation. J Urol, 172:290-4.
59. Mos J, Mollet I, Tolboom JT, et al. 1999. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol, 9:123-35.
60. Naseem KM, Mumtaz FH, Thompson CS, et al. 2000. Relaxation of rabbit lower urinary tract smooth muscle by nitric oxide and carbon monoxide: modulation by hydrogen peroxide. Eur J Pharmacol, 387:329-35.
61. Pfizer, Inc. 2005. Zoloft (sertraline hydrochloride) Tablets and Oral Concentrate prescribing information [online]. Accessed 11 April 2007. URL: http://www.zoloft.com/ZoloftUSPI.pdf.
62. Pryor JL, Althof S, Steidle C, et al. 2005. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation [abstract]. J Urol, 173:201, Abstract 740.
63. Rosen RC, Porst H, Montorsi F. 2004. The Premature Ejaculation Prevalence and Attitudes (PEPA) Survey: A multinational survey. J Sex Med, 1(suppl 1):57-8.
64. Rowland DL, Perelman M, Althof S, et al. 2004. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med, 1:225-232.
65. Sadovsky R, Miller T, Moskowitz M, et al. 2001. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract, 55:115-28.
66. Salonia A, Maga T, Colombo R, et al. 2002. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol, 168:2486-9.
67. Schultz K, Schultz K, Schultz G. 1977. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature, 265:750-1.
68. Segraves RT, Saran A, Segraves K, et al. 1993. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther, 19:198-200.
69. Shabsigh R, Perelman M. 2005. Men with both premature ejaculation (PE) and erectile dysfunction (ED) experience lower quality-of-life than men with either PE or ED alone. World Congress of Sexology. Montreal, Canada.
70. Shafik A. 1997. Pelvic floor muscles and sphincters during erection and ejaculation. Arch Androl, 39:71-8.
71. Shafik A. 1998. The mechanism of ejaculation:the glans-vasal and urethro-muscular reflexes. Arch Androl, 41:71-8.
72. Sharlip I. 2005. Diagnosis and treatment of premature ejaculation:the physician's perspective. J Sex Med, 2(Suppl 2):103-9.
73. Shenassa B, Hellstrom WJ. 2001. Understanding ejaculatory disorders. Contemp Urol, 13:51-59.
74. Sommer F, Klotz T. Mathers MJ. 2005. Treatment of premature ejaculation:a comperative vardenaffi and SSRI crossover study. AUA Annual Meeting. San Antonio, TX.
75. Stacey P, Rulten S, Dapling A. et al. 1998. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun, 247:249-54.
76. Stjarne L, Bartfai T, Alberts P. 1979. The influence of 8-Br 3′, 5′-cyclic nucleotide analogs and of inhibitors of 3′, 5′-cyclic nucleotide phosphodiesterase, on noradrenaline secretion and neuromuscular transmission in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol, 308:99-105.
77. Strassberg DS, de Gouveia Brazao CA, Rowland DL, et al. 1999. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther, 25:89-101.
78. Symonds T, Roblin D, Hart K, et al. 2003. How does premature ejaculation impact a mans life? J Sex Marital Ther, 29:361-70.
79. Takeda M, Tang R, Shapiro E, et al. 1995. Effects of nitric oxide on human and canine prostates. Urology, 45:440-6.
80. Uckert S, Kuthe A, Jonas U, et al. 2001. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol, 166:2484-90.
81. Waldinger MD. 2002. The neurobiological approach to premature ejaculation. J Urol, 168:2359-67.
82. Waldinger MD. 2003. Towards evidence-based drug treatment research on premature ejaculation:a critical evaluation of methodology. Int J Impot Res, 15:309-13.
83. Waldinger MD. 2005. Lifelong premature ejaculation:definition, serotonergic neurotransmission and drug treatment. World J Urol, 23:102-8.
84. Waldinger MD, Berendsen HH, Blok BF, et al. 1998a. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation:the involvement of the serotonergic system. Behav Brain Res, 92:111-8.
85. Waldinger MD, Hengeveld MW, Zwinderman AH. 1994. Paroxetine treatment of premature ejaculation:a double-blind, randomized, placebo-controlled study. Am J Psychiatry, 151:1377-9.
86. Waldinger MD, Hengeveld MW, Zwinderman AH, et al. 1998b. Effect of SSRI antidepressants on ejaculation:a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol, 18:274-81.
87. Waldinger MD, Quinn P, Dilleen M, et al. 2005a. A multinational population survey of intravaginal ejaculation latency time. J Sex Med, 2:492-7.
88. Waldinger MD, Schweitzer DH. 2005. Retarded ejaculation in men:an overview of psychological and neurobiological insights. World J Urol, 23:76-81.
89. Waldinger MD, Schweitzer DH, Olivier B. 2005b. On-demand SSRI treatment of premature ejaculation:pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med, 2:121-31.
90. Waldinger MD, van de Plas A, Pattij T, et al. 2002. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl), 160:283-9.
91. Waldinger MD, Zwinderman AH, Olivier B. 2004a. On-demand treatment of premature ejaculation with clomipramine and paroxetine:a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol, 46:510-5; discussion 516.
92. Waldinger MD, Zwinderman AR, Olivier B, et al. 2005c. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med, 2:498-507.
93. Waldinger MD, Zwinderman AH, Schweitzer DH, et al. 2004b. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res, 16:369-81.
94. Williams W. 1984. Secondary premature ejaculation. Aust N Z J Psychiatry, 18:333-40.
95. Witt MA, Grantmyre JE. 1993. Ejaculatory failure. World J Urol, 11:89-95.
96. Xin ZC, Choi YD, Lee SH, et al. 1997. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies. Yonsei Med J, 38:91-5.
97. Yanaka N, Kotera J, Ohtsuka A, et al. 1998. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem, 255:391-9.
98. Yang CC, Bradley WE. 1999. Somatic innervation of the human bulbocavernosus muscle. Clin Neurophysiol, 110:412-8.